FSD Pharma Inc.
FSD Pharma Inc. (HUGE) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
huge · pe ratio · data through Dec 31, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for FSD Pharma Inc. (HUGE) measures how much investors pay for each dollar of the company's trailing earnings. HUGE's current PE ratio of N/A is calculated by dividing its stock price of $0.09 by its TTM earnings per share of -$0.60.
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31
PE Ratio History
2015 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
FSD Pharma Inc.You HUGE | $0M | N/A | — | -$0.60 |
 Acorda Therapeutics, Inc. ACOR | $1M | N/A | — | -$203.59 |
 Biofrontera Inc. BFRI | $12M | N/A | — | -$1.04 |
 Craftport Cannabis Corp. BHHKF | $0M | N/A | — | -$0.49 |
 Cann American Corp. CNNA | $1M | 0.19x | +18.1% | $0.01 |
 City View Green Holdings Inc. CVGRF | $1M | N/A | — | -$0.02 |
 American Green, Inc. ERBB | $1M | 0.14x | -18.1% | $0.00 |
Industry Average 2 peers with valid PE | — | 0.16x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-12-31Latest FY2023 | — | $-0.47 | — | |
2022-12-31 FY2022 | — | $-0.60 | — | |
2021-12-31 FY2021 | — | $-1.01 | — | |
2020-12-31 FY2020 | — | $-2.72 | — | |
2019-12-31 FY2019 | — | $-5.64 | — | |
2018-12-31 FY2018 | — | $-2.82 | — | |
2017-12-31 FY2017 | — | $-0.43 | — | |
2016-08-31 FY2016 | — | $-0.00 | — | |
2015-08-31 FY2015 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for FSD Pharma Inc. (HUGE) measures how much investors pay for each dollar of the company's trailing earnings. HUGE's current PE ratio of N/A is calculated by dividing its stock price of $0.09 by its TTM earnings per share of -$0.60.
Frequently asked questions
HUGE pe ratio · 6 questionsHUGE's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.09 and TTM EPS of -$0.60. Data sourced from Financial Modeling Prep via HUGE's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · FSD Pharma Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09